This retatrutide vs tirzepatide page is written and maintained by a licensed clinical social worker who is also a personal GLP-1 user
Therefore, it is generally not recommended in these populations
For researchers transitioning from other compounds, specific dosing considerations apply
Why Titration Matters A slow, stepwise escalation remains the key to safety
If you're not sure what's stalling your results, we built a free tool that walks you through it in about 60 seconds: It identifies your exact phase, your specific issue, and gives you a personalized action plan including whether your dose, nutrition, training, or recovery is the actual bottleneck
Hyperglycemia and IR have been linked to increased -synuclein aggregation, further implicating the role of diabetes in the pathogenesis of PD [22]